1 year return (CAGR)
99.88%
UroGen Pharma Ltd Exchange (NASDAQ, USD)
URGN
33.75
-2.05 (-5.60%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
36.90%
5 year return (CAGR)
16.83%
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
1.69B
Price/Sales
8.95
Ent value
2.00B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
12.37
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 36.35 |
| Daily high | 36.91 |
| Daily low | 34.26 |
| Daily Volume | 1.05M |
| All-time high | 65.33 |
| 1y analyst estimate | 60.00 |
| Beta | 1.58 |
| EPS (TTM) | -1.94 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 12 Mar 2026 |
Downside potential
Loading...
Downside potential data
| URGN | S&P500 | |
| Current price drop from All-time high | -48.34% | -0.87% |
| Highest price drop | -93.98% | -56.47% |
| Date of highest drop | 27 May 2025 | 9 Mar 2009 |
| Avg drop from high | -60.58% | -10.65% |
| Avg time to new high | 55 days | 12 days |
| Max time to new high | 2115 days | 1805 days |
News
